Mashup Score:302
World Health OrganizationWHO launches new roadmap on breast cancer - 4 days
Mashup Score:302
# BreastCancer
Mashup Score:60
ScienceDirectPlease wait whilst we redirect you - 1 week
Mashup Score:60
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By...
-
Great updated review article on #oncofertility just out in @CBCjournal by @MRazeti & @UniGenova @SanMartino_Ge team: hope it can help improving the counseling of young #BreastCancer patients Free download for 50 days: https://t.co/nAUGqBTn17 @OncoAlert #UNIGEnonsiferma #bcsm https://t.co/nAUGqBTn17 - view on twitter
Mashup Score:46
MDPIEmerging Indications for Interventional Oncology: Expert Discussion on New Locoregional Treatments - 1 week
Mashup Score:46
Interventional oncology (IO) employs image-guided techniques to perform minimally invasive procedures, providing lower-risk alternatives to many traditional medical and surgical therapies for cancer patients....
-
Hot off the press in Cancers! Excellent overview of many emerging indications for #InterventionalOncology. Locoregional therapies for spine & skull base tumors, #breastcancer, head & neck cancer, intrahepatic cholangiocarcinoma & others discussed. #irad https://t.co/86QzbUsV9H https://t.co/86QzbUsV9H - view on twitter
Mashup Score:37
ascopost.comBy The ASCO Post Staff Posted: 2/3/2023 12:22:00 PM Last Updated: 2/3/2023 12:39:23 PM On February 3, the U.S. Food and Drug Administration (FDA)...
-
.@US_FDA Approves Sacituzumab Govitecan-hziy for Pretreated Patients With HR-Positive, HER2-Negative Breast Cancer https://t.co/GsgiIs4rd4 #bcsm #breastcancer #oncology @FDAOncology - view on twitter
Mashup Score:36
U.S. Food and Drug AdministrationFDA approves elacestrant for ER-positive - 1 week
Mashup Score:36
FDA approves elacestrant for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast...
-
JUST OUT @US_FDA 🇺🇸Approves elacestrant in postmenopausal women/adult men w/ER➕HER2➖ESR1🧬mutated advanced or metastatic #BreastCancer w/disease progression following at least 1️⃣line ET Decision based on Efficacy in EMERALD💎 @OncoAlert 🚨@FDAOncology https://t.co/B0cTY6nN11 https://t.co/B0cTY6nN11 - view on twitter
More coverage:
#breastcancer
Mashup Score:29
YouTubeThe 2022 OncoAlert Colloquium DAY 1: Breast Cancer - 2 days
Mashup Score:29
A warm welcome to the third OncoAlert ColloquiumThis year being held in partnership with: The American Society for Radiation OncologyThe European Cancer...
-
RT @OncoAlert: The #OncoAlertColloquium 🚨 3⃣,0⃣0⃣0⃣VIEWERS‼️ Day1⃣ #BreastCancer https://t.co/FHgVESaXZA Day2⃣GU Onc https://t.co/FHgVESaXZA - view on twitter
Mashup Score:29
YouTubeThe 2022 OncoAlert Colloquium DAY 1: Breast Cancer - 2 days
Mashup Score:29
A warm welcome to the third OncoAlert ColloquiumThis year being held in partnership with: The American Society for Radiation OncologyThe European Cancer...
-
RT @OncoAlert: The #OncoAlertColloquium 🚨 3⃣,0⃣0⃣0⃣VIEWERS‼️ Day1⃣ #BreastCancer https://t.co/FHgVESaXZA Day2⃣GU Onc https://t.co/FHgVESaXZA - view on twitter
Mashup Score:29
YouTubeThe 2022 OncoAlert Colloquium DAY 1: Breast Cancer - 10 hours
Mashup Score:29
A warm welcome to the third OncoAlert ColloquiumThis year being held in partnership with: The American Society for Radiation OncologyThe European Cancer...
-
RT @OncoAlert: Warm invite to the #OncoAlertColloquium 🚨 3⃣,3⃣0⃣0⃣➕VIEWERS‼️ 🆓FREE LINK🆓 Day1⃣ #BreastCancer https://t.co/FHgVESaqa2 @Eri… - view on twitter
Mashup Score:29
YouTubeThe 2022 OncoAlert Colloquium DAY 1: Breast Cancer - 4 days
Mashup Score:29
A warm welcome to the third OncoAlert ColloquiumThis year being held in partnership with: The American Society for Radiation OncologyThe European Cancer...
-
RT @OncoAlert: The #OncoAlertColloquium 🚨 3⃣,0⃣0⃣0⃣VIEWERS‼️ Day1⃣ #BreastCancer https://t.co/FHgVESaXZA Day2⃣GU Onc https://t.co/FHgVESaXZA - view on twitter
Mashup Score:28
YouTubeThe 2022 OncoAlert Colloquium DAY 1: Breast Cancer - 1 week
Mashup Score:28
A warm welcome to the third OncoAlert ColloquiumThis year being held in partnership with: The American Society for Radiation OncologyThe European Cancer...
-
RT @OncoAlert: The #OncoAlertColloquium 🚨Pls SHARE‼️ Day1⃣ #BreastCancer https://t.co/FHgVESaXZA Day2⃣GU Onc https://t.co/FHgVESaXZA Day… - view on twitter
The World Health Organization (WHO) released a new Global Breast Cancer Initiative Framework today providing a roadmap to attain the targets to save 2.5...
Tomorrow is #WorldCancerDay We can avoid 2.5 million deaths by 2040. WHO launches a new Global #BreastCancer Initiative Framework today to outline how: 📌 https://t.co/MazITkk8ne https://t.co/MazITkk8ne - view on twitter